Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (640)	12/21/1997 11:44:00 PM
From: Miljenko Zuanic	Read Replies (3) of 887

Hi Andrew: >>He was talking about scientific expertise, MZ, not investing expertise.<< Yes, I know. But, DEPO situation with DepoCyt wasn't clear and company fundamental with scientific expertise didn't help. Clinical trials results numbers was there from beginning and we all missed them (in interpretation). Most interesting, short missed to. It mean that company did cover toxicity story very well. I tried to bring attention to dropout issue but Tom overoptimism and other posters hype turned focus on projecting price movement instead on DepoCyt background. The point is that if I (we) can't spot hole in clinical data than scientific expertise can't be implemented. Bottom line: Regardless (if and when) DepoCyt approval or not, toxicity profile will kill this drug and market potential will be very limited. IMO, stock is dead money for long period of time. Best wishes for Holidays to you and all participant on this read. I am afraid that hope is all what we have for next several months. mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next